vimarsana.com
Home
Live Updates
Moderna, Inc.: EMA Committee for Medicinal Products for Human Use Issues Positive Opinion Recommending Authorization for the Use of Spikevax in Children 6 Months : vimarsana.com
Moderna, Inc.: EMA Committee for Medicinal Products for Human Use Issues Positive Opinion Recommending Authorization for the Use of Spikevax in Children 6 Months
Announcement follows CHMP's previous decision to issue a positive opinion recommending marketing authorization for Moderna's COVID-19 vaccine to include children 6 years of age and olderTwo-dose series
Related Keywords
Australia ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Canada ,
Lavina Talukdar ,
Luke Mircea Willats ,
Us Department Of Health ,
Human Services ,
National Institutes Of Health ,
Biomedical Advanced Research ,
National Institute Of Allergy ,
European Commission ,
Development Authority ,
Nasdaq ,
Exchange Commission ,
Corporate Communications ,
Moderna Inc ,
European Medicines Agency ,
Office Of The ,
Committee For Medicinal Products Human Use ,
Medicinal Products ,
Human Use ,
Chief Executive ,
National Institute ,
Infectious Diseases ,
National Institutes ,
Assistant Secretary ,
Conditional Marketing Authorization ,
Private Securities Litigation Reform Act ,
Annual Report ,
Quarterly Report ,
Vice President ,
Moderna ,
Committee ,
Medicinal ,
Products ,
Human ,
Issues ,
Positive ,
Opinion ,
Recommending ,
Authorization ,
Spikevax ,
Children ,
Months ,
Tears ,
European ,
Union ,
vimarsana.com © 2020. All Rights Reserved.